CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $47,000 | -47.2% | 11,265 | -58.6% | 0.00% | – |
| Q3 2021 | $89,000 | -51.4% | 27,233 | -37.4% | 0.00% | -100.0% |
| Q2 2021 | $183,000 | -3.2% | 43,469 | +14.7% | 0.00% | 0.0% |
| Q1 2021 | $189,000 | -5.5% | 37,912 | +85.9% | 0.00% | -66.7% |
| Q3 2020 | $200,000 | -46.7% | 20,393 | -52.0% | 0.00% | -70.0% |
| Q1 2020 | $375,000 | -32.8% | 42,469 | -29.8% | 0.01% | +233.3% |
| Q4 2019 | $558,000 | +45.7% | 60,527 | -7.2% | 0.00% | 0.0% |
| Q3 2019 | $383,000 | +51.4% | 65,200 | +209.1% | 0.00% | +50.0% |
| Q2 2019 | $253,000 | +17.1% | 21,096 | +17.7% | 0.00% | 0.0% |
| Q1 2019 | $216,000 | -65.5% | 17,926 | -57.5% | 0.00% | -71.4% |
| Q3 2018 | $626,000 | -3.8% | 42,200 | +9.0% | 0.01% | -22.2% |
| Q2 2018 | $651,000 | +22.4% | 38,700 | +66.6% | 0.01% | +12.5% |
| Q1 2018 | $532,000 | +6.8% | 23,236 | +20.6% | 0.01% | -11.1% |
| Q4 2017 | $498,000 | +57.1% | 19,263 | -10.4% | 0.01% | +50.0% |
| Q3 2017 | $317,000 | +38.4% | 21,500 | +31.1% | 0.01% | +20.0% |
| Q2 2017 | $229,000 | -2.6% | 16,400 | +19.2% | 0.01% | -16.7% |
| Q1 2017 | $235,000 | -35.3% | 13,764 | -61.0% | 0.01% | -60.0% |
| Q4 2016 | $363,000 | – | 35,325 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |